Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obstetric Labor, Premature | 17 | 2018 | 58 | 4.780 |
Why?
|
Premature Birth | 12 | 2023 | 113 | 3.600 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2015 | 105 | 3.000 |
Why?
|
Escherichia coli Infections | 9 | 2018 | 35 | 2.850 |
Why?
|
Pregnancy | 44 | 2023 | 2894 | 2.730 |
Why?
|
Labor, Obstetric | 3 | 2023 | 46 | 1.940 |
Why?
|
Fetal Membranes, Premature Rupture | 3 | 2023 | 18 | 1.890 |
Why?
|
Uterus | 13 | 2018 | 215 | 1.740 |
Why?
|
Toll-Like Receptor 2 | 5 | 2020 | 33 | 1.690 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 39 | 1.640 |
Why?
|
Placenta | 10 | 2023 | 175 | 1.480 |
Why?
|
Myeloid Differentiation Factor 88 | 4 | 2015 | 47 | 1.370 |
Why?
|
Inflammation | 8 | 2023 | 923 | 1.360 |
Why?
|
Cesarean Section | 3 | 2019 | 137 | 1.310 |
Why?
|
Macrophages | 8 | 2022 | 557 | 1.170 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 2 | 2018 | 4 | 1.130 |
Why?
|
Progesterone | 6 | 2023 | 110 | 1.040 |
Why?
|
Escherichia coli | 6 | 2018 | 597 | 1.020 |
Why?
|
Streptococcus agalactiae | 3 | 2015 | 11 | 1.010 |
Why?
|
Female | 51 | 2023 | 44550 | 0.980 |
Why?
|
Glucose Tolerance Test | 2 | 2022 | 228 | 0.980 |
Why?
|
Streptococcal Infections | 3 | 2015 | 57 | 0.980 |
Why?
|
Pregnancy Complications | 3 | 2021 | 336 | 0.970 |
Why?
|
Isothiocyanates | 1 | 2022 | 7 | 0.900 |
Why?
|
Phenol | 1 | 2022 | 7 | 0.890 |
Why?
|
Toll-Like Receptor 4 | 5 | 2015 | 88 | 0.880 |
Why?
|
Uterine Cervical Incompetence | 1 | 2022 | 4 | 0.870 |
Why?
|
Physician-Patient Relations | 2 | 2018 | 610 | 0.870 |
Why?
|
Cerclage, Cervical | 1 | 2022 | 5 | 0.870 |
Why?
|
Mice | 26 | 2022 | 11356 | 0.840 |
Why?
|
Perineum | 2 | 2014 | 35 | 0.810 |
Why?
|
Myometrium | 2 | 2020 | 46 | 0.780 |
Why?
|
Interleukin-1 | 4 | 2006 | 71 | 0.770 |
Why?
|
Toll-Like Receptor 7 | 1 | 2020 | 8 | 0.740 |
Why?
|
Endometritis | 1 | 2019 | 2 | 0.730 |
Why?
|
DNA Virus Infections | 1 | 2020 | 6 | 0.730 |
Why?
|
Genital Diseases, Female | 1 | 2020 | 24 | 0.730 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 23 | 0.720 |
Why?
|
Patient Care Bundles | 1 | 2019 | 20 | 0.710 |
Why?
|
Poly I-C | 4 | 2015 | 16 | 0.680 |
Why?
|
Receptors, Notch | 2 | 2015 | 120 | 0.640 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 184 | 0.630 |
Why?
|
Anger | 1 | 2018 | 78 | 0.620 |
Why?
|
Animals | 31 | 2022 | 26590 | 0.620 |
Why?
|
Signal Transduction | 9 | 2015 | 3243 | 0.610 |
Why?
|
Patients | 1 | 2018 | 100 | 0.610 |
Why?
|
Receptors, Interleukin-1 | 3 | 2006 | 11 | 0.610 |
Why?
|
Peptidoglycan | 4 | 2015 | 31 | 0.600 |
Why?
|
Infant, Newborn | 6 | 2023 | 2379 | 0.590 |
Why?
|
Cognition | 1 | 2021 | 571 | 0.590 |
Why?
|
Toll-Like Receptors | 4 | 2011 | 92 | 0.570 |
Why?
|
Vaginal Smears | 1 | 2016 | 68 | 0.560 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 51 | 0.550 |
Why?
|
Lipopolysaccharides | 5 | 2018 | 286 | 0.550 |
Why?
|
Patient Advocacy | 1 | 2016 | 49 | 0.550 |
Why?
|
Receptors, Progesterone | 2 | 2023 | 167 | 0.530 |
Why?
|
Medical Errors | 1 | 2016 | 115 | 0.520 |
Why?
|
Humans | 31 | 2023 | 86678 | 0.500 |
Why?
|
Obstetrics | 1 | 2016 | 120 | 0.500 |
Why?
|
Platelet Activating Factor | 1 | 2014 | 53 | 0.500 |
Why?
|
Adaptor Proteins, Vesicular Transport | 2 | 2014 | 49 | 0.500 |
Why?
|
Extraction, Obstetrical | 1 | 2014 | 7 | 0.500 |
Why?
|
Obstetric Labor Complications | 1 | 2014 | 34 | 0.480 |
Why?
|
RNA, Messenger | 4 | 2015 | 1981 | 0.480 |
Why?
|
Inflammation Mediators | 5 | 2020 | 155 | 0.480 |
Why?
|
Membrane Proteins | 4 | 2015 | 1196 | 0.480 |
Why?
|
Neutrophils | 1 | 2015 | 307 | 0.470 |
Why?
|
Mice, Knockout | 8 | 2015 | 1924 | 0.460 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 275 | 0.460 |
Why?
|
Autophagy | 1 | 2015 | 149 | 0.450 |
Why?
|
Obstetrical Forceps | 2 | 2014 | 9 | 0.450 |
Why?
|
Vacuum Extraction, Obstetrical | 2 | 2014 | 6 | 0.450 |
Why?
|
Fetus | 5 | 2015 | 226 | 0.450 |
Why?
|
Education, Medical | 1 | 2016 | 234 | 0.440 |
Why?
|
Quality of Health Care | 1 | 2016 | 381 | 0.440 |
Why?
|
Mice, Inbred C57BL | 9 | 2017 | 3095 | 0.440 |
Why?
|
Bacterial Infections | 2 | 2005 | 182 | 0.430 |
Why?
|
Lacerations | 2 | 2014 | 28 | 0.430 |
Why?
|
Disease Models, Animal | 9 | 2017 | 2231 | 0.410 |
Why?
|
Toll-Like Receptor 3 | 2 | 2010 | 9 | 0.400 |
Why?
|
Practice Patterns, Physicians' | 1 | 2016 | 584 | 0.380 |
Why?
|
Cyclooxygenase 2 | 4 | 2015 | 100 | 0.380 |
Why?
|
Meteorological Concepts | 1 | 2010 | 2 | 0.380 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 339 | 0.380 |
Why?
|
Parturition | 1 | 2010 | 21 | 0.370 |
Why?
|
Gestational Age | 4 | 2023 | 311 | 0.370 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2009 | 25 | 0.370 |
Why?
|
Caspase Inhibitors | 1 | 2009 | 33 | 0.360 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2009 | 53 | 0.360 |
Why?
|
Mice, Inbred C3H | 5 | 2017 | 370 | 0.350 |
Why?
|
Reperfusion Injury | 3 | 2017 | 131 | 0.340 |
Why?
|
Gene Expression | 4 | 2015 | 1284 | 0.340 |
Why?
|
Seasons | 1 | 2010 | 223 | 0.340 |
Why?
|
Physicians | 1 | 2016 | 674 | 0.330 |
Why?
|
Interleukin-6 | 2 | 2015 | 256 | 0.330 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 2 | 2005 | 6 | 0.330 |
Why?
|
Labor Presentation | 1 | 2008 | 4 | 0.330 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 37 | 0.320 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2015 | 683 | 0.320 |
Why?
|
Cytokines | 5 | 2015 | 778 | 0.310 |
Why?
|
Vagina | 3 | 2012 | 161 | 0.290 |
Why?
|
Logistic Models | 2 | 2021 | 1188 | 0.290 |
Why?
|
Internship and Residency | 1 | 2016 | 1010 | 0.290 |
Why?
|
Case-Control Studies | 4 | 2020 | 1807 | 0.280 |
Why?
|
Fetal Growth Retardation | 3 | 2017 | 66 | 0.280 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2006 | 43 | 0.280 |
Why?
|
Pregnancy Trimester, Second | 2 | 2022 | 66 | 0.280 |
Why?
|
Fetal Death | 3 | 2015 | 56 | 0.270 |
Why?
|
Wound Healing | 3 | 2012 | 344 | 0.270 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 286 | 0.270 |
Why?
|
Mice, Mutant Strains | 5 | 2013 | 229 | 0.260 |
Why?
|
Interleukin-1beta | 2 | 2015 | 78 | 0.260 |
Why?
|
NF-kappa B | 3 | 2015 | 445 | 0.260 |
Why?
|
Up-Regulation | 3 | 2018 | 715 | 0.260 |
Why?
|
Retrospective Studies | 5 | 2023 | 8496 | 0.250 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 428 | 0.250 |
Why?
|
Multivariate Analysis | 2 | 2019 | 1001 | 0.250 |
Why?
|
Adult | 8 | 2021 | 25659 | 0.240 |
Why?
|
Hydroxyprogesterones | 1 | 2023 | 22 | 0.240 |
Why?
|
Enzymes | 1 | 2003 | 47 | 0.230 |
Why?
|
Amniotic Fluid | 1 | 2023 | 30 | 0.220 |
Why?
|
Phenols | 1 | 2022 | 40 | 0.220 |
Why?
|
Cells, Cultured | 4 | 2015 | 2819 | 0.220 |
Why?
|
Cervix Uteri | 1 | 2022 | 65 | 0.210 |
Why?
|
Risk Factors | 3 | 2021 | 5420 | 0.210 |
Why?
|
Cell Line | 2 | 2020 | 2469 | 0.210 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2012 | 87 | 0.210 |
Why?
|
Pregnancy, Animal | 1 | 2002 | 58 | 0.210 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 928 | 0.210 |
Why?
|
Clinical Competence | 2 | 2018 | 756 | 0.200 |
Why?
|
Pregnancy Trimester, First | 1 | 2021 | 63 | 0.200 |
Why?
|
Bias | 1 | 2021 | 127 | 0.190 |
Why?
|
Torque teno virus | 1 | 2020 | 1 | 0.180 |
Why?
|
Chlorhexidine | 1 | 2019 | 2 | 0.180 |
Why?
|
Mass Screening | 2 | 2022 | 619 | 0.180 |
Why?
|
Povidone-Iodine | 1 | 2019 | 8 | 0.180 |
Why?
|
Glucose | 1 | 2022 | 638 | 0.180 |
Why?
|
Uncertainty | 1 | 2020 | 71 | 0.180 |
Why?
|
Uterine Diseases | 2 | 2013 | 19 | 0.170 |
Why?
|
Skin | 2 | 2012 | 554 | 0.170 |
Why?
|
Chorioamnionitis | 2 | 2017 | 15 | 0.170 |
Why?
|
Diagnostic Errors | 1 | 2020 | 160 | 0.170 |
Why?
|
Administration, Intravenous | 1 | 2018 | 50 | 0.160 |
Why?
|
Blood Glucose | 1 | 2022 | 873 | 0.160 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 1921 | 0.160 |
Why?
|
Mice, Inbred Strains | 2 | 2015 | 307 | 0.160 |
Why?
|
Body Mass Index | 1 | 2021 | 770 | 0.150 |
Why?
|
Interleukins | 1 | 2018 | 134 | 0.150 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2015 | 273 | 0.150 |
Why?
|
Fraud | 1 | 2016 | 6 | 0.150 |
Why?
|
Patient Education as Topic | 1 | 2019 | 351 | 0.140 |
Why?
|
Papanicolaou Test | 1 | 2016 | 38 | 0.140 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 220 | 0.140 |
Why?
|
Malpractice | 1 | 2016 | 57 | 0.140 |
Why?
|
Odds Ratio | 2 | 2015 | 680 | 0.140 |
Why?
|
Polynucleotides | 1 | 2015 | 17 | 0.140 |
Why?
|
Immunohistochemistry | 3 | 2009 | 1753 | 0.140 |
Why?
|
Transcription Factor HES-1 | 1 | 2015 | 7 | 0.140 |
Why?
|
Decidua | 1 | 2015 | 19 | 0.140 |
Why?
|
Carrier State | 1 | 2015 | 39 | 0.140 |
Why?
|
Prospective Studies | 2 | 2020 | 4214 | 0.130 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 1566 | 0.130 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2015 | 4 | 0.130 |
Why?
|
Chemokines | 1 | 2015 | 73 | 0.130 |
Why?
|
Autophagy-Related Proteins | 1 | 2015 | 21 | 0.130 |
Why?
|
Autophagy-Related Protein 7 | 1 | 2015 | 12 | 0.130 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2015 | 19 | 0.130 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 115 | 0.130 |
Why?
|
Phagosomes | 1 | 2015 | 39 | 0.130 |
Why?
|
Recurrence | 2 | 2015 | 1139 | 0.130 |
Why?
|
Male | 6 | 2018 | 40988 | 0.130 |
Why?
|
Cysteine Endopeptidases | 1 | 2015 | 87 | 0.130 |
Why?
|
Maternal Age | 1 | 2014 | 44 | 0.130 |
Why?
|
Caspases | 2 | 2018 | 155 | 0.130 |
Why?
|
Cyclooxygenase 1 | 2 | 2005 | 5 | 0.130 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 35 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 179 | 0.130 |
Why?
|
Heterozygote | 1 | 2015 | 365 | 0.120 |
Why?
|
Parity | 1 | 2014 | 93 | 0.120 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 747 | 0.120 |
Why?
|
Lysosomes | 1 | 2015 | 104 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 165 | 0.120 |
Why?
|
Models, Animal | 1 | 2015 | 263 | 0.120 |
Why?
|
Epistasis, Genetic | 1 | 2014 | 86 | 0.120 |
Why?
|
Clinical Decision-Making | 1 | 2016 | 257 | 0.120 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 425 | 0.120 |
Why?
|
Proton-Translocating ATPases | 1 | 2013 | 23 | 0.120 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 192 | 0.120 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 176 | 0.120 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2005 | 214 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 104 | 0.110 |
Why?
|
RNA | 2 | 2009 | 560 | 0.110 |
Why?
|
Ligands | 2 | 2013 | 433 | 0.110 |
Why?
|
Colpotomy | 1 | 2012 | 4 | 0.110 |
Why?
|
Complement C5 | 1 | 2012 | 14 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2012 | 27 | 0.110 |
Why?
|
Menopause | 1 | 2012 | 71 | 0.110 |
Why?
|
Surgeons | 1 | 2016 | 238 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2013 | 409 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 536 | 0.100 |
Why?
|
Cell Membrane | 1 | 2014 | 666 | 0.100 |
Why?
|
Fatty Acids | 1 | 2011 | 130 | 0.100 |
Why?
|
Gene-Environment Interaction | 1 | 2011 | 103 | 0.090 |
Why?
|
Peroxidase | 3 | 2017 | 51 | 0.090 |
Why?
|
Cell Line, Transformed | 1 | 2010 | 154 | 0.090 |
Why?
|
Extraembryonic Membranes | 1 | 2009 | 8 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 121 | 0.090 |
Why?
|
Ovarian Follicle | 1 | 2009 | 72 | 0.090 |
Why?
|
Calpain | 1 | 2009 | 111 | 0.090 |
Why?
|
Receptors, Interleukin | 1 | 2009 | 35 | 0.080 |
Why?
|
Illinois | 1 | 2010 | 462 | 0.080 |
Why?
|
Ovariectomy | 2 | 2012 | 81 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 308 | 0.080 |
Why?
|
Teichoic Acids | 1 | 2007 | 18 | 0.070 |
Why?
|
Apoptosis | 2 | 2013 | 1683 | 0.070 |
Why?
|
Rabbits | 3 | 2012 | 636 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 879 | 0.070 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2006 | 5 | 0.070 |
Why?
|
Cervical Ripening | 1 | 2006 | 4 | 0.070 |
Why?
|
Infant | 2 | 2023 | 3047 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 1221 | 0.070 |
Why?
|
Fetal Weight | 2 | 2017 | 15 | 0.070 |
Why?
|
Aged, 80 and over | 1 | 2016 | 6513 | 0.070 |
Why?
|
Pregnancy Trimester, Third | 1 | 2005 | 70 | 0.070 |
Why?
|
Organ Size | 2 | 2017 | 364 | 0.060 |
Why?
|
DNA Primers | 1 | 2005 | 543 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2005 | 1540 | 0.060 |
Why?
|
Gravidity | 1 | 2023 | 7 | 0.060 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2023 | 31 | 0.060 |
Why?
|
Prostaglandins | 1 | 2003 | 43 | 0.060 |
Why?
|
Proteomics | 1 | 2005 | 211 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 2357 | 0.060 |
Why?
|
Isoenzymes | 1 | 2003 | 271 | 0.050 |
Why?
|
Foam Cells | 1 | 2002 | 17 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2002 | 31 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2008 | 1802 | 0.050 |
Why?
|
Rats | 1 | 2009 | 3992 | 0.050 |
Why?
|
Genotype | 2 | 2003 | 1852 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2003 | 1015 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2022 | 247 | 0.050 |
Why?
|
Cholesterol | 1 | 2002 | 356 | 0.050 |
Why?
|
Genomics | 1 | 2005 | 720 | 0.040 |
Why?
|
Fas Ligand Protein | 1 | 2018 | 49 | 0.040 |
Why?
|
Uterine Cervicitis | 1 | 2017 | 4 | 0.040 |
Why?
|
Biomarkers | 2 | 2013 | 1718 | 0.040 |
Why?
|
Risk Assessment | 1 | 2023 | 2264 | 0.030 |
Why?
|
Caspase 1 | 1 | 2013 | 18 | 0.030 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 22 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 49 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2013 | 94 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2011 | 7 | 0.030 |
Why?
|
Boston | 1 | 2011 | 33 | 0.030 |
Why?
|
Random Allocation | 1 | 2012 | 332 | 0.030 |
Why?
|
Calcinosis | 1 | 2013 | 224 | 0.030 |
Why?
|
Glutathione Transferase | 1 | 2011 | 111 | 0.030 |
Why?
|
Estrogens | 1 | 2012 | 200 | 0.020 |
Why?
|
Mutation | 1 | 2002 | 3968 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 692 | 0.020 |
Why?
|
Urban Population | 1 | 2011 | 214 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2013 | 673 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2011 | 294 | 0.020 |
Why?
|
Young Adult | 2 | 2011 | 5980 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 819 | 0.020 |
Why?
|
Cholates | 1 | 2002 | 1 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 11 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2002 | 171 | 0.010 |
Why?
|
Lipoproteins | 1 | 2002 | 135 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 435 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 8984 | 0.010 |
Why?
|